Navigating CAR-T cell therapy long-term complications.

GREGOIRE, Céline; Melenhorst, J Joseph

doi:10.1038/s43018-024-00867-1

Request a copy

Article (Scientific journals)

Navigating CAR-T cell therapy long-term complications.

GREGOIRE, Céline; Melenhorst, J Joseph

2024 • In Nature Cancer, 5, p. 1768-1770

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/330144

DOI
10.1038/s43018-024-00867-1

PubMed
39690224

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

812 Gregoire.pdf

Publisher postprint (1.5 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

CAR T cells; Hematologic malignancies; Infections; Secondary cancer

Disciplines :

Hematology
Immunology & infectious disease
Biochemistry, biophysics & molecular biology
Laboratory medicine & medical technology

Author, co-author :

GREGOIRE, Céline ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique ; Center for ImmunoTherapy & Precision Immuno-Oncology (CITI), Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

Melenhorst, J Joseph ; Center for ImmunoTherapy & Precision Immuno-Oncology (CITI), Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. melenhj@ccf.org

Language :

English

Title :

Navigating CAR-T cell therapy long-term complications.

Publication date :

2024

Journal title :

Nature Cancer

eISSN :

2662-1347

Publisher :

Springer Science and Business Media LLC, England

Volume :

Pages :

1768-1770

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://www.nature.com/articles/s43018-024-00867-1.pdf

Available on ORBi :

since 31 March 2025

Statistics

Number of views

21 (2 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

D.M. Cordas Dos Santos Nat. Med. 30 2667 2678 1:CAS:528:DC%2BB2cXhsFSlurnO 10.1038/s41591-024-03084-6 38977912
T. Tix et al. Clin. Cancer Res. 30 4690 4700 10.1158/1078-0432.CCR-24-1798 39256908
M.P. Hamilton et al. N. Engl. J. Med. 390 2047 2060 1:CAS:528:DC%2BB2cXhvVaiur7O 10.1056/NEJMoa2401361 38865660 11338600
M. Ozdemirli et al. N. Engl. J. Med. 390 2074 2082 1:CAS:528:DC%2BB2cXhvVaiur7I 10.1056/NEJMoa2401530 38865661
S.J. Harrison et al. Blood 142 6939 10.1182/blood-2023-178806
P. Berning et al. Blood Cancer J. 14 10.1038/s41408-024-01085-9 38969655 11226679 106
L. Garderet et al. Am. J. Hematol. 99 2084 2095 1:CAS:528:DC%2BB2cXhslygsbfK 10.1002/ajh.27451 39158218
M. Shadman et al. Blood Cancer J. 14 10.1038/s41408-024-01084-w 38977682 11231252 108
K. Rejeski Blood Adv. 8 1857 1868 10.1182/bloodadvances.2023011767 38181508 11007437
K. Rejeski et al. J. Immunother. Cancer 10 e004475 10.1136/jitc-2021-004475 35580927 9114843
V. Panagiota et al. Hemasphere 7 e957 1:CAS:528:DC%2BB2cXhvVeru7s%3D 10.1097/HS9.0000000000000957 37799345 10550045
G. Ghilardi et al. Nat. Med. 30 984 989 1:CAS:528:DC%2BB2cXksFKrsr0%3D 10.1038/s41591-024-02826-w 38266761
J.A. Fraietta et al. Nature 558 307 312 1:CAS:528:DC%2BC1cXhtVGitL3I 10.1038/s41586-018-0178-z 29849141 6320248
N.N. Shah et al. Blood Adv. 3 2317 2322 10.1182/bloodadvances.2019000219 31387880 6693002
K.P. Micklethwaite et al. Blood 138 1391 1405 1:CAS:528:DC%2BB3MXitlSrurfN 10.1182/blood.2021010858 33974080 8532197